Shao-An Xue
Professor Xi-An University
Seminars
Thursday 26th February 2026
Development of TCR Technology Platforms for Cancer Immunotherapy
12:00 pm
- Highlight how next-generation of single chain TCR can prevent mispairing
- Share preclinical insights showing the potential of engineered stimulatory PD-L1 signalling for solid tumour applications
- Showcase the platform of targeted transduction for nonactivated T-cells
